Nigerian-German Chemicals PLC

NGSE:NIG-GERMAN Stock Report

Mkt Cap: ₦556.7m

We’ve recently updated our valuation analysis.

Nigerian-German Chemicals Valuation

Is NIG-GERMAN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for NIG-GERMAN?

Other financial metrics that can be useful for relative valuation.

NIG-GERMAN key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenuen/a
Enterprise Value/EBITDAn/a
PEG Ration/a

Price to Book Ratio vs Peers

How does NIG-GERMAN's PB Ratio compare to its peers?

The above table shows the PB ratio for NIG-GERMAN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPBEstimated GrowthMarket Cap
Peer Average1.5x
NEIMETH Neimeth International Pharmaceuticals
2.7xn/a₦3.0b
MAYBAKER May & Baker Nigeria
0.9xn/a₦7.7b
GLAXOSMITH GlaxoSmithKline Consumer Nigeria
0.8xn/a₦7.8b
FIDSON Fidson Healthcare
1.4xn/a₦22.7b
NIG-GERMAN Nigerian-German Chemicals
n/an/a₦556.7m

Price-To-Book vs Peers: Insufficient data to calculate NIG-GERMAN's Price-To-Book Ratio vs. peers for valuation analysis.


Price to Earnings Ratio vs Industry

How does NIG-GERMAN's PE Ratio compare vs other companies in the African Pharmaceuticals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a7.4%
n/an/an/a

Price-To-Book vs Industry: Insufficient data to calculate NIG-GERMAN's Price-To-Book Ratio vs. industry for valuation analysis.


Price to Book Ratio vs Fair Ratio

What is NIG-GERMAN's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

NIG-GERMAN PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ration/a
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate NIG-GERMAN's Price-To-Book Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of NIG-GERMAN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate NIG-GERMAN's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate NIG-GERMAN's fair value for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies